William Sandborn

Last updated on 2013-08-23T10:01+0300.

About this image

sign

Quotes... Extracted quotes from

William Sandborn said : “Direct administration of drug therapies via ingestible technologies shows tremendous promise to improve treatment outcomes in patients with gastrointestinal diseases,” External link

4-traders Monday, October 28, 2019 11:35:00 PM EAT

William Sandborn said : "The symptoms of Crohn's disease can cause significant distress to many patients, which is why it's important to find a treatment that can act rapidly to reduce the impact of the disease. These new results from the UNITI-1 trial are encouraging because they demonstrate that treatment with ustekinumab may begin to reduce patient reported symptoms of Crohn's disease within just 1-2 weeks for a number of patients," External link

finanznachrichten-en Monday, October 30, 2017 6:37:00 PM EAT

William Sandborn said : "In a small Phase 1b trial not statistically powered to demonstrate efficacy, it is remarkable to see compelling directional change in local biological effect for patients receiving TD-1473, particularly a change in rectal bleeding and endoscopic subscores. Further, these effects were measured after just four weeks of treatment, a timeframe shorter than the typical induction endpoint in ulcerative colitis trials," External link

prnewswire Tuesday, August 8, 2017 11:59:00 PM EAT

William Sandborn said : "Maintaining control of disease symptoms is paramount in the treatment of Crohn's disease. The two-year clinical response and remission rates from the IM-UNITI study provide further evidence that ustekinumab can be an effective therapeutic option for people living with this chronic and often debilitating disease," External link

finanznachrichten-en Friday, February 17, 2017 12:19:00 PM EAT

William Sandborn said : "Maintaining control of disease symptoms is paramount in the treatment of Crohn's disease. The two-year clinical response and remission rates from the IM-UNITI study provide further evidence that ustekinumab can be an effective therapeutic option for people living with this chronic and often debilitating disease," External link

afp-en Friday, February 17, 2017 11:50:00 AM EAT

William Sandborn said : “At this early 12-week timepoint, we’re looking at the proportion of patients who had a 25 percent or greater endoscopic improvement, suggesting mucosal healing is underway in these patients,” External link

4-traders Monday, September 12, 2016 2:46:00 PM EAT

William Sandborn said : "The totality of the induction and maintenance data over the course of one year show the potential of this biologic therapy in inducing and maintaining a clinically relevant therapeutic effect in patients with moderate to severe Crohn's disease," External link

prnewswire Tuesday, May 24, 2016 3:43:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
professor57.14%EN02/17/201717/02/2017
directeur28.57%FR08/22/201322/08/2013
diretor14.29%PT08/22/201322/08/2013
Names Lang Count
William SandbornEN75.00%
William SandbornFR12.50%
William SandbornPT12.50%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, November 17, 2019

1:13:00 AM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

William Sandborn

Last updated on 2013-08-23T10:01+0300.

About this image

sign

Quotes... Extracted quotes from

William Sandborn said : “Direct administration of drug therapies via ingestible technologies shows tremendous promise to improve treatment outcomes in patients with gastrointestinal diseases,” External link

4-traders Monday, October 28, 2019 11:35:00 PM EAT

William Sandborn said : "The symptoms of Crohn's disease can cause significant distress to many patients, which is why it's important to find a treatment that can act rapidly to reduce the impact of the disease. These new results from the UNITI-1 trial are encouraging because they demonstrate that treatment with ustekinumab may begin to reduce patient reported symptoms of Crohn's disease within just 1-2 weeks for a number of patients," External link

finanznachrichten-en Monday, October 30, 2017 6:37:00 PM EAT

William Sandborn said : "In a small Phase 1b trial not statistically powered to demonstrate efficacy, it is remarkable to see compelling directional change in local biological effect for patients receiving TD-1473, particularly a change in rectal bleeding and endoscopic subscores. Further, these effects were measured after just four weeks of treatment, a timeframe shorter than the typical induction endpoint in ulcerative colitis trials," External link

prnewswire Tuesday, August 8, 2017 11:59:00 PM EAT

William Sandborn said : "Maintaining control of disease symptoms is paramount in the treatment of Crohn's disease. The two-year clinical response and remission rates from the IM-UNITI study provide further evidence that ustekinumab can be an effective therapeutic option for people living with this chronic and often debilitating disease," External link

finanznachrichten-en Friday, February 17, 2017 12:19:00 PM EAT

William Sandborn said : "Maintaining control of disease symptoms is paramount in the treatment of Crohn's disease. The two-year clinical response and remission rates from the IM-UNITI study provide further evidence that ustekinumab can be an effective therapeutic option for people living with this chronic and often debilitating disease," External link

afp-en Friday, February 17, 2017 11:50:00 AM EAT

William Sandborn said : “At this early 12-week timepoint, we’re looking at the proportion of patients who had a 25 percent or greater endoscopic improvement, suggesting mucosal healing is underway in these patients,” External link

4-traders Monday, September 12, 2016 2:46:00 PM EAT

William Sandborn said : "The totality of the induction and maintenance data over the course of one year show the potential of this biologic therapy in inducing and maintaining a clinically relevant therapeutic effect in patients with moderate to severe Crohn's disease," External link

prnewswire Tuesday, May 24, 2016 3:43:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
professor57.14%EN02/17/201717/02/2017
directeur28.57%FR08/22/201322/08/2013
diretor14.29%PT08/22/201322/08/2013
Names Lang Count
William SandbornEN75.00%
William SandbornFR12.50%
William SandbornPT12.50%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, November 17, 2019

1:13:00 AM EAT


Quotes... Explore Relations


EMM Visual Explorer